➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Baxter
McKinsey
Express Scripts
Boehringer Ingelheim

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

PROCHLORPERAZINE EDISYLATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Prochlorperazine Edisylate patents expire, and what generic alternatives are available?

Prochlorperazine Edisylate is a drug marketed by Morton Grove, Athenex Inc, Emcure Pharms Ltd, Hospira, Marsam Pharms Llc, Mylan Labs Ltd, Nexus Pharms, Smith And Nephew, Teva Parenteral, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, and Alpharma Us Pharms. and is included in seventeen NDAs.

The generic ingredient in PROCHLORPERAZINE EDISYLATE is prochlorperazine edisylate. There are twenty-one drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the prochlorperazine edisylate profile page.

US ANDA Litigation and Generic Entry Outlook for Prochlorperazine Edisylate

A generic version of PROCHLORPERAZINE EDISYLATE was approved as prochlorperazine edisylate by WEST-WARD PHARMS INT on August 29th, 1989.

  Start Trial

Summary for PROCHLORPERAZINE EDISYLATE
Drug patent expirations by year for PROCHLORPERAZINE EDISYLATE
Pharmacology for PROCHLORPERAZINE EDISYLATE
Drug ClassPhenothiazine

US Patents and Regulatory Information for PROCHLORPERAZINE EDISYLATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Morton Grove PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate CONCENTRATE;ORAL 088598-001 Oct 25, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Nexus Pharms PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate INJECTABLE;INJECTION 204860-001 Feb 15, 2019 AP RX No No   Start Trial   Start Trial   Start Trial
Hospira PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate INJECTABLE;INJECTION 089703-001 Apr 7, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate INJECTABLE;INJECTION 089606-001 Jul 8, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Smith And Nephew PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate INJECTABLE;INJECTION 089251-001 Dec 4, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Alpharma Us Pharms PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate SYRUP;ORAL 087154-001 Sep 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
AstraZeneca
McKesson
McKinsey
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.